Citra Anticoagulants

Citra Anticoagulants is a specialized medical company focused on the development and manufacturing of anticoagulant solutions for vascular access and catheter maintenance. Based in the Netherlands, the company is best known for its Citra-Lock product range, which utilizes trisodium citrate in various concentrations (4%, 30%, and 46.7%) to prevent catheter-related complications. These products are primarily used in hemodialysis and intensive care to maintain catheter patency and reduce the risk of catheter-related bloodstream infections (CRBSI). The company's solutions are recognized for their efficacy in biofilm reduction and as a safer alternative to heparin-based locks. Citra Anticoagulants operates internationally, supporting healthcare providers in nephrology and vascular medicine.